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Abstract
Shiffman rightly raises questions about who exercises power in global health, suggesting power is a complex 
concept, and the way it is exercised is often opaque. Power that is not based on financial strength but on 
knowledge or experience, is difficult to estimate, and yet it may provide the legitimacy to make moral claims 
on what is, or ought to be, on global health agendas. Twenty years ago power was exercised in a much less 
complex health environment. The World Health Organization (WHO) was able to exert its authority as world 
health leader. The landscape today is very different. Financial resources for global health are being competed 
for by diverse organisations, and power is diffused and somewhat hidden in such a climate, where each 
organization has to establish and make its own moral claims loudly and publicly. We observe two ways which 
allow actors to capture moral authority in global health. One, through power based on scientific knowledge 
and two, through procedures in the policy process, most commonly associated with the notion of broad 
consultation and participation. We discuss these drawing on one particular framework provided by Bourdieu, 
who analyses the source of actor power by focusing on different sorts of capital. Different approaches or 
theories to understanding power will go some way to answering the challenge Shiffman throws to health 
policy analysts. We need to explore much more fully where power lies in global health, and how it is exercised 
in order to understand underlying health agendas and claims to legitimacy made by global health actors today.
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Shiffman (1) rightly raises questions about who exercises power in global health, suggesting power is a complex concept, and the way it is exercised is often opaque. 
Financial power, such as that of large donor country 
governments, for example, or major lending institutions such 
as the World Bank or International Monetary Fund (IMF) 
is not difficult to understand. But what about those who 
use other aspects of power to try to influence global health 
agendas? Power that is not based on financial strength but 
on knowledge, science or experience, is sometimes more 
difficult to estimate, and yet it may provide the legitimacy 
to make moral claims on what is, or ought to be, on global 
health agendas. 
Twenty years ago power was exercised in a much less complex 
health environment. The World Health Organization (WHO) 
was able to exert its authority as world health leader in two 
ways. One, through its ability to draw on and coordinate, 
the views of experts and professionals throughout the world 
(epistemic communities of scientists); and two, through 
its being a membership organization which included 
most countries in the world, including rich and poor, with 
equal voting rights. Member states recognized WHO’s 
legitimacy to draw attention to issues that needed attention, 
and to make decisions about ways to tackle problems and 
implement global policies. WHO’s moral authority was thus 
derived first from its ability to draw on and debate, clinical 
and scientific evidence and expertise and second, from its 
political mandate stemming from the WHO Constitution – a 
document recognised in international law – and signed by its 
Member States.
However, the landscape today is very different. Financial 
resources for global health are being competed for by diverse 
organisations: public-private partnerships, research bodies 
and universities, non-government organizations, as well as 
international organizations such as WHO. Where once three-
quarters of  WHO’s finances were generated from membership 
contributions, and only a quarter were earmarked funds 
from external donors (2), today the situation is reversed (3). 
Today WHO has less financial power, in a world where funds 
are much more diffused, and where many organizations 
compete to access health resources and to influence the 
global health agenda. But also, WHO’s moral authority has 
been undermined (partly because of the changed economic 
landscape), and its expertise is often challenged by other 
organizations (4,5). Shiffman points to the example of the 
International Health Metrics Institute (IHME) and the 
extent to which its expertise – measuring the global burden 
of disease – has impacted on discourse and priorities in the 
field of global health, leading to contention over global figures 
on malaria. Similarly, WHO has been challenged in the case 
Hanefeld and Walt 
International Journal of Health Policy and Management, 2015, 4(2), 119–121120
of the recent Ebola outbreak. It was the non-governmental 
organisation Medecins Sans Frontieres (MSF) whose high 
profile interventions, including at the UN Security Council, 
which was seen as having mobilised the international 
response. MSF’s credibility and authority stemmed from its 
early involvement in this and earlier outbreaks and WHO was 
perceived to have been slow and distant in its recognition of 
the implications of Ebola for the region. A further example 
cited by Shiffman, is that of the medical journal, The Lancet, 
whose editor has, through linking with epistemic networks 
around the world, ensured that the journal itself has emerged 
as a powerful actor in global health. Its power is partly derived 
from being the most highly cited journal in the field. This 
power, plus the ability to attract resources has enabled The 
Lancet to become a key convening forum for debate and for 
setting global health priorities. 
Shiffman’s gaze on the role of these epistemic communities is 
timely: we need to know more about why some organizations 
or individual leaders are accorded legitimacy yet others are 
neglected or spurned. We observe below two ways which 
allow actors to capture moral authority in global health. We 
discuss these in turn and explore very briefly just one political 
science concept of power, proposed by Bourdieu (6,7) which 
health policy analysts may find useful. Like Shiffman, we 
hope that other concepts of  power will be explored in relation 
to issues in global health policy to improve our understanding 
of how power is exercised. 
First, over the past twenty years ‘evidence-based’ policy-
making in global health has gained huge attention and 
currency (8,9). Recognition of health policy processes as 
political and non-linear (10), has led to greater efforts to 
translate the principles of evidence-based medicine into 
health policy decision-making including at the global level. 
The organizations which provide evidence and present it to 
implementing authorities have gained power in this climate. 
The authority of the IHME and The Lancet are testimony of 
this trend, deriving power and legitimacy from their claim 
to scientific knowledge and evidence. However, creating the 
evidence that allows organisations to claim moral authority 
and legitimacy in global health requires significant economic 
resources. The IHME and its Global Burden of Disease 
research has relied very heavily on funding from the Gates 
Foundation, which has emerged as a major funder in global 
health – not only of interventions – but also of research over 
the past two decades (11). While evidence is often perceived 
as ‘neutral’ or ‘scientific’ as long as it comes from authoritative 
sources, there has been limited attention on how financial 
resources used to gather evidence may have influenced its 
creation and presentation. Here the questions posed by 
Shiffman are particularly pertinent and need to be explored 
much more thoroughly. 
Second, we need to explore more about the procedures 
that lead to claims of moral authority. For example, many 
governments, global institutions and organizations argue 
that they are meeting democratic deficits by having long 
consultative processes in deciding policies. One example is 
the process to establish the new Sustainable Development 
Goals (SDGs) post 2015. Proponents of these long processes 
suggest that opportunities for participation have led to 
more being involved in the processes of policy-making. But 
little research has been undertaken to demonstrate how 
participative are such processes, whose voices are being 
included, whose excluded – or how far small groups of 
elites may actually control these. We know little about the 
extent to which individuals and groups may be captured 
in the name of participation and greater democracy. More 
questions are being raised as to the huge costs of consultation 
and participation processes in time and travel alone, and 
their relationship with greater efficiency or better decisions 
or policies. Consultations risk becoming synonymous with 
a mandate, without greater interrogation of the effect and 
meaning of such processes. 
One framework for analysing actor power in this context 
is provided by the work of Pierre Bourdieu whose theory 
of different capitals deepens our understanding of power 
beyond immediate economic assets. Bourdieu suggests that 
power originates from a multiplicity of sources. He recognises 
cultural capital derived from education, academic titles, 
epistemic knowledge and recognised experience as one 
source of power. This helps to explain the claim to moral 
authority by the examples suggested by Shiffman – the IHME 
and The Lancet – as well as the position of WHO. Yet much 
of their power is enabled or reliant on the economic capital of 
funders such as the Gates Foundation, who in turn rely on 
academic institutions to transform their economic capital into 
cultural capital in the form of scientific evidence. Economic 
capital thus may influence the type of cultural capital by 
determining the type of research undertaken, the sort of 
evidence that is well-regarded, how the evidence is presented 
and advocated. Relationships between research institutions 
and funders may thus influence what evidence-based 
research is translated into policy solutions. Social capital, in 
Bourdieu’s framework denominates the links and connections 
between networks of organisations and individuals, and 
how these links facilitate access to different types of capital. 
By exploring more thoroughly actors’ social capital, we will 
understand better how legitimacy is established between 
actors and organisations, derived from procedural claims of 
consultation and participation. Connection to a wide range of 
organisations or a large number of individuals within a policy 
process increases social capital, and raises moral claims. The 
last of Bourdieu’s capitals – symbolic capital – is perhaps the 
most elusive and context specific of the four types of power, 
but the claim that WHO was ‘the world’s conscience’ (12) is 
characteristic of this sort of power. WHO’s guidelines and 
policy directives are based on cultural, social but also symbolic 
power – they have no legal status in Member States, who, 
nevertheless, will often use them to create national legislation 
or policy in turn. 
Bourdieu’s capitals provide just one instrument to help health 
analysts understand who has power and why, and how it is 
exercised in global health. Other approaches and frameworks 
also encourage insights into these complex questions. We 
support Shiffman’s call for more transparency and greater 
interrogation of knowledge, moral claims and the exercise of 
power in global health. We need to explore much more fully 
where power lies in global health, and how it is exercised in 
order to understand underlying health agendas and claims to 
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